A more valid measurement of low-density lipoprotein cholesterol in diabetic patients

American Journal of Medicine

Volumn 102, Issue 1, 1997, Pages 48-53

  Hirany, Shaina ^a   Li, Dai ^a   Jialal, Ishwarlal ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACCURACY; ARTICLE; ASSAY; DIABETES MELLITUS; DYSLIPIDEMIA; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

CHOLESTEROL, LDL; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; MATHEMATICAL COMPUTING; PREDICTIVE VALUE OF TESTS; ULTRACENTRIFUGATION;

EID: 0031040327     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00375-0     Document Type: Article

References (22)

1. Bierman EL. Atherogenesis in diabetes. Arterioscler Thromb. 1992;12: 647-656.
2. Orchard TJ. Dyslipoproteinemia and diabetes. Endocrinol Metab Clin North Am. 1990;19:361-379.
3. Jialal I, Chait A. Pathogenesis of macroangiopathy. In: Draznin B, Melmed S, LeRoith D, eds. Complications of Diabetes Mellitus. New York: Alan R. Liss; 1989:69-75.
4. Reaven GM. Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Am J Med. 1987;83:31-40.
5. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 1987;28:613-627.
6. Howard BV. Lipids and lipoprotein metabolism in diabetes mellitus. In: Draznin B, Melmed S, LeRoith D, eds. Complications of Diabetes Mellitus. New York: Alan R. Liss; 1989:59-67.
7. Rubies-Prat J, Reverter JL, Senti M, et al. Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus. Diabet Care. 1993;8:1081-1086.
8. National Cholesterol Education Program. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Summary of the second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (ATP II). JAMA. 1993;269:3015-3023.
9. American Diabetes Association. Clinical Practice Recommendations 1995. Detection and management of lipid disorders in diabetes. Diabet Care. 1995;18:86-93.
10. Jialal I, Hirany SH, Deveraj S, Sherwood TA. Comparison of an immunoprecipitation method for direct measurement of LDL cholesterol with beta-quantification (ultracentrifugation). Am J Clin Pathol. 1995;104:76-81.
11. McNamara JR, Cole TG, Contois JH, et al. Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated. Clin Chem. 1995;41:232-240.
12. Pisani T, Gebski CP, Leary ET, et al. Accurate direct determination of low-density lipoprotein cholesterol using an immunoseparation reagent and enzymatic cholesterol assay. Arch Pathol Lab Med. 1995;119:1127-1135.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
14. Chait A, Bierman EL. Pathogenesis of macrovascular disease in diabetes. In: Kahn CR, Weir GC, eds. Joslin's Diabetes Mellitus. Lea and Febiger; 1994:648-664.
15. Weisweiler P, Schwandt P. Type 1 (insulin-dependent) versus type 2 (non-insulin-dependent) diabetes mellitus: characterization of serum lipoprotein alterations. Eur J Clin Inv. 1987;17:87-91.
16. Betteridge DJ. Diabetic dyslipidemia. Am J Med. 1994;96(suppl 6A):25S-31S.
17. Warnick RG, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem. 1990;36:15-19.
18. McNamara JR, Cohn JS, Wilson PWF, Schaefer EJ. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem. 1990;36:36-42.
19. Marniemi J, Maki J, Maatela, et al. Poor applicability of the Friedewald formula in theassessment of serum LDL cholesterol for clinical purposes. Clin Biochem. 1995;28:285-289.
20. Winocour PH, Ishola M, Durringtong PN. Validation of the Friedewald formula for the measurement of low density lipoprotein cholesterol in insulin-dependent diabetes mellitus. Clin Chim Acta. 1989;179:79-84.
21. Garg A, Grundy SM. Management of dyslipidemia in NIDDM. Diabet Care. 1990;13:153-169.
22. Pyorala K, Pederson J, Kjekshus J. The effect of cholesterol lowering with simvastatin on coronary events in diabetic patients with coronary heart disease. Diabetes. 1995;44 (suppl 1):35A.